PTX3 and systemic inflammatory response syndrome: Thus, we developed a novel assay for measurement of PTX3 in body fluids and examined the serum levels from patients with SIRS and sepsis admitted to an ICU as well as controls in order to review the validity of PTX3 as a biomarker in ICU patients.